The nurse is caring for a client who is being treated for peptic ulcer disease. Which medication should the client be taught to avoid?

A) H2-receptor blockers:
H2-receptor blockers, such as ranitidine and famotidine, are used to reduce the production of stomach acid. While they can provide symptomatic relief for ulcers by reducing acid secretion, they do not directly treat the underlying cause of the ulcer, which is the H. pylori infection.

B) Antacids:
Antacids are medications that neutralize stomach acid and can provide temporary relief from ulcer symptoms such as pain and discomfort. However, they do not eradicate the H. pylori bacteria or address the root cause of the ulcer. Antacids only provide symptomatic relief rather than treating the infection.

C) Proton-pump inhibitors:
Proton-pump inhibitors (PPIs), such as omeprazole and pantoprazole, are potent acid-suppressing medications that are commonly used to treat ulcers and gastroesophageal reflux disease (GERD). While they can help in ulcer healing by reducing acid secretion and providing symptomatic relief, they are not effective in eradicating H. pylori infection. PPIs are often used in combination with antibiotics for H. pylori eradication therapy, but they are not the primary treatment on their own.

D) Antibiotics.
H. pylori (Helicobacter pylori) is a bacteria that commonly infects the stomach lining and is a major cause of gastric and duodenal ulcers. Antibiotics are the primary treatment for H. pylori infection. The antibiotics kill the bacteria, allowing the ulcer to heal. Common antibiotics used to treat H. pylori include amoxicillin, clarithromycin, metronidazole, and tetracycline.

A) Low-back pain:
Low-back pain is not a common manifestation of an allergic reaction to a blood transfusion. It may be associated with other conditions, such as musculoskeletal issues or renal complications, but it is not typically addressed by diphenhydramine administration during transfusion.

B) Fever:
While fever can occur as a manifestation of an adverse reaction to a blood transfusion, it is more commonly associated with non-allergic transfusion reactions such as transfusion-related acute lung injury (TRALI) or bacterial contamination of the blood product. Diphenhydramine is not specifically indicated for the prevention of fever during transfusion.

C) Dyspnea:
Dyspnea, or difficulty breathing, can occur as a manifestation of a severe allergic reaction or anaphylaxis during a blood transfusion. However, diphenhydramine alone may not be sufficient to prevent or treat severe respiratory symptoms associated with anaphylaxis. In such cases, prompt medical intervention and administration of epinephrine may be necessary. Diphenhydramine primarily targets histamine-mediated symptoms such as urticaria and itching.

D) Urticaria.
Urticaria, commonly known as hives, is a skin reaction characterized by raised, itchy welts that can occur as a result of an allergic or hypersensitivity reaction. During a blood transfusion, if the recipient's immune system reacts to foreign proteins in the transfused blood, it can lead to an allergic reaction characterized by symptoms such as urticaria, itching, flushing, and sometimes more severe reactions like anaphylaxis.
Diphenhydramine is an antihistamine medication that works by blocking the effects of histamine, a chemical released by the body during allergic reactions. By administering diphenhydramine before the blood transfusion, the nurse aims to prevent or minimize the occurrence of urticaria and other allergic symptoms.